Bond AbbVie Inc. 4.25% ( US00287YBF51 ) in USD
Issuer | AbbVie Inc. | ||
Market price | ![]() |
||
Country | ![]() |
||
ISIN code |
![]() |
||
Interest rate | 4.25% per year ( payment 2 times a year) | ||
Maturity | 13/11/2028 | ||
|
|||
Minimal amount | 2 000 USD | ||
Total amount | 1 750 000 000 USD | ||
Cusip | 00287YBF5 | ||
Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||
Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||
Next Coupon | 14/11/2025 ( In 165 days ) | ||
Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBF51, pays a coupon of 4.25% per year. The coupons are paid 2 times per year and the Bond maturity is 13/11/2028 The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBF51, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBF51, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |